Companies faced with real or threatened FDA sanctions are usually least prepared to react effectively.
Maxine Fritz
Advertisement
Articles by Maxine Fritz
Advertisement
Latest Updated Articles
A Systems-Based Team Approach to GMP CompliancePublished: September 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
